Advancement of pediatric blood and marrow transplantation research in North America: Priorities of the pediatric blood and marrow transplant consortium

Michael A. Pulsipher, Edwin M. Horwitz, Ann E. Haight, Richard Kadota, Allen R. Chen, Haydar Frangoul, Laurence J N Cooper, David A. Jacobsohn, Rakesh K. Goyal, David Mitchell, Michael L. Nieder, Gregory Yanik, Morton J. Cowan, Sandeep Soni, Sharon Gardner, Shalini Shenoy, Douglas Taylor, Mitchell Cairo, Kirk R. Schultz

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Advances in pediatric bone marrow transplantation (BMT) are slowed by the small number of patients with a given disease who undergo transplantation, a lack of sufficient infrastructure to run early-phase oncology protocols and studies of rare nonmalignant disorders, and challenges associated with funding multi-institutional trials. Leadership of the Pediatric Blood and Marrow Transplant Consortium (PBMTC), a large pediatric BMT clinical trials network representing 77 active and 45 affiliated centers worldwide, met in April 2009 to develop strategic plans to address these issues. Key barriers, including infrastructure development and funding, along with scientific initiatives in malignant and nonmalignant disorders, cellular therapeutics, graft-versus-host disease, and supportive care were discussed. The PBMTC's agenda for approaching these issues will result in infrastructure and trials specific to pediatrics that will run through the PBMTC or its partners, the Blood and Marrow Transplant Clinical Trials Network and the Children's Oncology Group.

Original languageEnglish (US)
Pages (from-to)1212-1221
Number of pages10
JournalBiology of Blood and Marrow Transplantation
Volume16
Issue number9
DOIs
StatePublished - Sep 2010

Fingerprint

North America
Transplantation
Bone Marrow
Pediatrics
Transplants
Research
Bone Marrow Transplantation
Clinical Trials
Graft vs Host Disease
Therapeutics

Keywords

  • Cooperative Group Studies
  • Hematopoietic Stem Cell Transplantation
  • Pediatrics
  • Transplantation of Non-malignant Disorders

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Advancement of pediatric blood and marrow transplantation research in North America : Priorities of the pediatric blood and marrow transplant consortium. / Pulsipher, Michael A.; Horwitz, Edwin M.; Haight, Ann E.; Kadota, Richard; Chen, Allen R.; Frangoul, Haydar; Cooper, Laurence J N; Jacobsohn, David A.; Goyal, Rakesh K.; Mitchell, David; Nieder, Michael L.; Yanik, Gregory; Cowan, Morton J.; Soni, Sandeep; Gardner, Sharon; Shenoy, Shalini; Taylor, Douglas; Cairo, Mitchell; Schultz, Kirk R.

In: Biology of Blood and Marrow Transplantation, Vol. 16, No. 9, 09.2010, p. 1212-1221.

Research output: Contribution to journalArticle

Pulsipher, MA, Horwitz, EM, Haight, AE, Kadota, R, Chen, AR, Frangoul, H, Cooper, LJN, Jacobsohn, DA, Goyal, RK, Mitchell, D, Nieder, ML, Yanik, G, Cowan, MJ, Soni, S, Gardner, S, Shenoy, S, Taylor, D, Cairo, M & Schultz, KR 2010, 'Advancement of pediatric blood and marrow transplantation research in North America: Priorities of the pediatric blood and marrow transplant consortium', Biology of Blood and Marrow Transplantation, vol. 16, no. 9, pp. 1212-1221. https://doi.org/10.1016/j.bbmt.2009.12.536
Pulsipher, Michael A. ; Horwitz, Edwin M. ; Haight, Ann E. ; Kadota, Richard ; Chen, Allen R. ; Frangoul, Haydar ; Cooper, Laurence J N ; Jacobsohn, David A. ; Goyal, Rakesh K. ; Mitchell, David ; Nieder, Michael L. ; Yanik, Gregory ; Cowan, Morton J. ; Soni, Sandeep ; Gardner, Sharon ; Shenoy, Shalini ; Taylor, Douglas ; Cairo, Mitchell ; Schultz, Kirk R. / Advancement of pediatric blood and marrow transplantation research in North America : Priorities of the pediatric blood and marrow transplant consortium. In: Biology of Blood and Marrow Transplantation. 2010 ; Vol. 16, No. 9. pp. 1212-1221.
@article{3ff20b03e28347c48190608b85e6007d,
title = "Advancement of pediatric blood and marrow transplantation research in North America: Priorities of the pediatric blood and marrow transplant consortium",
abstract = "Advances in pediatric bone marrow transplantation (BMT) are slowed by the small number of patients with a given disease who undergo transplantation, a lack of sufficient infrastructure to run early-phase oncology protocols and studies of rare nonmalignant disorders, and challenges associated with funding multi-institutional trials. Leadership of the Pediatric Blood and Marrow Transplant Consortium (PBMTC), a large pediatric BMT clinical trials network representing 77 active and 45 affiliated centers worldwide, met in April 2009 to develop strategic plans to address these issues. Key barriers, including infrastructure development and funding, along with scientific initiatives in malignant and nonmalignant disorders, cellular therapeutics, graft-versus-host disease, and supportive care were discussed. The PBMTC's agenda for approaching these issues will result in infrastructure and trials specific to pediatrics that will run through the PBMTC or its partners, the Blood and Marrow Transplant Clinical Trials Network and the Children's Oncology Group.",
keywords = "Cooperative Group Studies, Hematopoietic Stem Cell Transplantation, Pediatrics, Transplantation of Non-malignant Disorders",
author = "Pulsipher, {Michael A.} and Horwitz, {Edwin M.} and Haight, {Ann E.} and Richard Kadota and Chen, {Allen R.} and Haydar Frangoul and Cooper, {Laurence J N} and Jacobsohn, {David A.} and Goyal, {Rakesh K.} and David Mitchell and Nieder, {Michael L.} and Gregory Yanik and Cowan, {Morton J.} and Sandeep Soni and Sharon Gardner and Shalini Shenoy and Douglas Taylor and Mitchell Cairo and Schultz, {Kirk R.}",
year = "2010",
month = "9",
doi = "10.1016/j.bbmt.2009.12.536",
language = "English (US)",
volume = "16",
pages = "1212--1221",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Advancement of pediatric blood and marrow transplantation research in North America

T2 - Priorities of the pediatric blood and marrow transplant consortium

AU - Pulsipher, Michael A.

AU - Horwitz, Edwin M.

AU - Haight, Ann E.

AU - Kadota, Richard

AU - Chen, Allen R.

AU - Frangoul, Haydar

AU - Cooper, Laurence J N

AU - Jacobsohn, David A.

AU - Goyal, Rakesh K.

AU - Mitchell, David

AU - Nieder, Michael L.

AU - Yanik, Gregory

AU - Cowan, Morton J.

AU - Soni, Sandeep

AU - Gardner, Sharon

AU - Shenoy, Shalini

AU - Taylor, Douglas

AU - Cairo, Mitchell

AU - Schultz, Kirk R.

PY - 2010/9

Y1 - 2010/9

N2 - Advances in pediatric bone marrow transplantation (BMT) are slowed by the small number of patients with a given disease who undergo transplantation, a lack of sufficient infrastructure to run early-phase oncology protocols and studies of rare nonmalignant disorders, and challenges associated with funding multi-institutional trials. Leadership of the Pediatric Blood and Marrow Transplant Consortium (PBMTC), a large pediatric BMT clinical trials network representing 77 active and 45 affiliated centers worldwide, met in April 2009 to develop strategic plans to address these issues. Key barriers, including infrastructure development and funding, along with scientific initiatives in malignant and nonmalignant disorders, cellular therapeutics, graft-versus-host disease, and supportive care were discussed. The PBMTC's agenda for approaching these issues will result in infrastructure and trials specific to pediatrics that will run through the PBMTC or its partners, the Blood and Marrow Transplant Clinical Trials Network and the Children's Oncology Group.

AB - Advances in pediatric bone marrow transplantation (BMT) are slowed by the small number of patients with a given disease who undergo transplantation, a lack of sufficient infrastructure to run early-phase oncology protocols and studies of rare nonmalignant disorders, and challenges associated with funding multi-institutional trials. Leadership of the Pediatric Blood and Marrow Transplant Consortium (PBMTC), a large pediatric BMT clinical trials network representing 77 active and 45 affiliated centers worldwide, met in April 2009 to develop strategic plans to address these issues. Key barriers, including infrastructure development and funding, along with scientific initiatives in malignant and nonmalignant disorders, cellular therapeutics, graft-versus-host disease, and supportive care were discussed. The PBMTC's agenda for approaching these issues will result in infrastructure and trials specific to pediatrics that will run through the PBMTC or its partners, the Blood and Marrow Transplant Clinical Trials Network and the Children's Oncology Group.

KW - Cooperative Group Studies

KW - Hematopoietic Stem Cell Transplantation

KW - Pediatrics

KW - Transplantation of Non-malignant Disorders

UR - http://www.scopus.com/inward/record.url?scp=77955509680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955509680&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2009.12.536

DO - 10.1016/j.bbmt.2009.12.536

M3 - Article

C2 - 20079865

AN - SCOPUS:77955509680

VL - 16

SP - 1212

EP - 1221

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 9

ER -